healthwarehouse.com inc (HEWA:OTC US)
healthwarehouse.com inc (HEWA) Snapshot
|
Open
$1.50
|
Previous Close
$1.45
|
|
|
Day High
$1.80
|
Day Low
$1.50
|
|
|
52 Week High
06/20/12 - $7.25
|
52 Week Low
05/21/13 - $0.69
|
|
|
Market Cap
44.7M
|
Average Volume 10 Days
1.3K
|
|
|
EPS TTM
$-0.69
|
Shares Outstanding
24.8M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
healthwarehouse.com inc (HEWA) Related Businessweek News
No Related Businessweek News Foundhealthwarehouse.com inc (HEWA) Details
Healthwarehouse.com, Inc. operates as a virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs, as well as over-the-counter (OTC) medical products in the United States. The company sells a range of prescription drugs; diabetic supplies, including glucometers, lancets, syringes, and test strips; and OTC medications covering a range of conditions from allergy and sinus to pain and fever to smoking cessation aids. It also offers home medical supplies, such as incontinence supplies, first aid kits, and mobility aids; and diet and nutritional products comprising supplements, weight loss aids, and vitamins and minerals. In addition, Healthwarehouse.com, Inc. operates as a licensed mail-order pharmacy for sales to 50 states and the District of Columbia. The company sells its products directly to the individual consumers of the pharmaceutical and non-pharmaceutical products. Healthwarehouse.com, Inc. is headquartered in Florence, Kentucky.
Last Reported Date: 06/22/12
healthwarehouse.com inc (HEWA) Top Compensated Officers
healthwarehouse.com inc (HEWA) Key Developments
On May 7, 2013, a putative shareholder derivative action was filed in the Court of Chancery of the State of Delaware against HealthWarehouse.com, Inc. and certain directors and an officer of the company alleging claims for breach of fiduciary duty, entrenchment and corporate waste. The derivative complaint seeks unspecified compensatory damages and other relief.
On April 29, 2013, John Backus submitted a letter addressed to the board of directors of HealthWarehouse.com, Inc. in which he informed the company of his resignation as a director on the board, effective immediately.
On March 28, 2013, HealthWarehouse.com, Inc., Hwareh.com, Inc. and Hocks.com, Inc. entered into a promissory note and a security agreement with Melrose Capital Advisors, LLC. Under the terms of the note, the company borrowed $500,000 from the Melrose on March 28, 2013. The proceeds of the loan will be used by the company for working capital purposes. The loan bears interest at a floating rate equal to the prime rate plus 4.25% per annum. Interest is payable monthly beginning May 1, 2013. The maturity date of the Loan is March 1, 2015. Under the terms of the security agreement, the company granted the Lender a first priority security interest in all of the company’s assets, in order to secure the company’s obligation to repay the loan. The note and security agreement contain customary affirmative and negative covenants, including covenants restricting the company’s ability to take certain actions without the Melrose’s consent, such as incurring additional indebtedness, transferring or encumbering assets, paying dividends or making certain other payments, and acquiring other businesses. The payment of the loan may be accelerated prior to its maturity date upon certain specified events of default, including failure to pay, bankruptcy, breach of covenant, and breach of representations and warranties. In consideration of the loan, the company granted the Lender a warrant to purchase 750,000 shares of HealthWarehouse.com, Inc.’s $0.001 par value common stock at a purchase price of $0.35 per share. The warrant may be exercised in whole or in part and from time to time for a term of five years from its grant date. The warrant contains a cashless exercise feature and certain customary anti-dilution adjustment provisions. The warrant is transferable in whole or in part, so long as the transfer complies with applicable securities laws. The lender exercised the warrant on April 1, 2013 in a “cashless” transaction, and will receive 573,826 “net” shares of common stock.

| Recently Viewed | |||
| HEWA:US | $1.80 USD | +0.35 | |
| Company | Last | Change | |
| No competitor information is available for HEWA. | |||
| View Industry Companies | |||
Industry Analysis
HEWA
Industry Average
| Valuation | HEWA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 1.5x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 2.9x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact HEALTHWAREHOUSE.COM INC, please visit www.healthwarehouse.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








